NewsBenzinga케로스 테라퓨틱스, 뒤쉔 근이영양증 환자 대상 린바테르셉트 2상 임상시험에서 첫 환자 투여 케로스 테라퓨틱스, 뒤쉔 근이영양증 환자 대상 린바테르셉트 2상 임상시험에서 첫 환자 투여 Benzinga 2026.09.28 12:03 (GMT+0) Open on Benzinga Other news Replit is no longer working with Anthropic, CEO says BOK Financial Corporation's Drop Opens A Door To An Upgrade (BOKF) How to Play NFLX Stock as Netflix Wipes Out Another 1,000 Jobs in Its Latest Round of Layoffs Why Micron Is Betting $35 Billion on Its Own Stock With Cathie Wood Warning of a Vicious Cycle in Memory Chipmakers, Here’s How You Should Play SKHY Stock Now Crypto Super PAC Fairshake Pours Millions More Into Defeating Sherrod Brown
With Cathie Wood Warning of a Vicious Cycle in Memory Chipmakers, Here’s How You Should Play SKHY Stock Now
